Literature DB >> 27778252

Successful Treatment of an Unusual Case of FPLD2: The Role of Roux-en-Y Gastric Bypass-Case Report and Literature Review.

Sharon Grundfest-Broniatowski1, JingLiang Yan2, Matthew Kroh2, Holly Kilim3, Andrew Stephenson4.   

Abstract

Familial partial lipodystrophy type 2 (FPLD2) is a rare disorder associated with LMNA gene mutations. It is usually marked by loss of subcutaneous fat on the limbs and trunk and severe insulin resistance. Scattered reports have indicated that Roux-en-Y bypass helps to control the diabetes mellitus in these patients. We present here a very unusual patient with FPLD2 who had life-threatening retroperitoneal and renal fat accumulation accompanied by bilateral renal cancers. Following cryotherapy of one renal cancer and a contralateral nephrectomy with debulking of the retroperitoneal fat, Roux-en-Y gastric bypass (RYGB) has successfully controlled the disease for 3 years. The clinical presentations and causes of FPLD are reviewed and the role of RYGB is discussed.

Entities:  

Keywords:  LMNA mutation; Laminopathy; Partial familial lipodystrophy; Retroperitoneal mass; Roux-en-Y gastric bypass

Mesh:

Year:  2016        PMID: 27778252     DOI: 10.1007/s11605-016-3300-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  19 in total

Review 1.  MANAGEMENT OF ENDOCRINE DISEASE: Metabolic effects of bariatric surgery.

Authors:  Ricard Corcelles; Christopher R Daigle; Philip R Schauer
Journal:  Eur J Endocrinol       Date:  2015-09-04       Impact factor: 6.664

2.  Gastric bypass for insulin resistance due to lipodystrophy.

Authors:  Nicole M McGrath; Govind Krishna
Journal:  Obes Surg       Date:  2006-11       Impact factor: 4.129

3.  Effectiveness of gastric bypass surgery in a patient with familial partial lipodystrophy.

Authors:  Kristina M Utzschneider; Dace L Trence
Journal:  Diabetes Care       Date:  2006-06       Impact factor: 19.112

4.  Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy.

Authors:  D Araújo-Vilar; G Lattanzi; B González-Méndez; A T Costa-Freitas; D Prieto; M Columbaro; E Mattioli; B Victoria; N Martínez-Sánchez; A Ramazanova; M Fraga; A Beiras; J Forteza; L Domínguez-Gerpe; C Calvo; J Lado-Abeal
Journal:  J Med Genet       Date:  2008-09-19       Impact factor: 6.318

5.  Familial lipoatrophic diabetes with dominant transmission. A new syndrome.

Authors:  M G Dunnigan; M A Cochrane; A Kelly; J W Scott
Journal:  Q J Med       Date:  1974-01

6.  Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.

Authors:  Patricia B Mory; Felipe Crispim; Maria Beatriz S Freire; João Eduardo N Salles; Cynthia M Valério; Amelio F Godoy-Matos; Sérgio A Dib; Regina S Moisés
Journal:  Eur J Endocrinol       Date:  2012-06-14       Impact factor: 6.664

7.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

8.  Post-mortem findings in familial partial lipodystrophy, Dunnigan variety.

Authors:  W A Haque; F Vuitch; A Garg
Journal:  Diabet Med       Date:  2002-12       Impact factor: 4.359

9.  Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.

Authors:  M Caron; M Auclair; B Donadille; V Béréziat; B Guerci; M Laville; H Narbonne; C Bodemer; O Lascols; J Capeau; C Vigouroux
Journal:  Cell Death Differ       Date:  2007-07-06       Impact factor: 15.828

10.  Increased skeletal muscle volume in women with familial partial lipodystrophy, Dunnigan variety.

Authors:  Hongzhao Ji; Paul Weatherall; Beverley Adams-Huet; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2013-06-19       Impact factor: 5.958

View more
  6 in total

Review 1.  Lipodystrophy for the Diabetologist-What to Look For.

Authors:  Nivedita Patni; Abhimanyu Garg
Journal:  Curr Diab Rep       Date:  2022-07-11       Impact factor: 5.430

2.  Approach to the Patient With Lipodystrophy.

Authors:  Lindsay T Fourman; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

Review 3.  What lipodystrophies teach us about the metabolic syndrome.

Authors:  Jake P Mann; David B Savage
Journal:  J Clin Invest       Date:  2019-08-05       Impact factor: 14.808

Review 4.  Update on Therapeutic Options in Lipodystrophy.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-10-29       Impact factor: 4.810

5.  Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome'.

Authors:  Antonio Atalaia; Rabah Ben Yaou; Karim Wahbi; Annachiara De Sandre-Giovannoli; Corinne Vigouroux; Gisèle Bonne
Journal:  J Neuromuscul Dis       Date:  2021

6.  Roux-en-Y Gastric Bypass Surgery in the Management of Familial Partial Lipodystrophy Type 1.

Authors:  Audrey Melvin; Claire Adams; Catherine Flanagan; Lisa Gaff; Barbara Gratton; Fiona Gribble; Geoffrey Roberts; Robert K Semple; Stephen O'Rahilly; Francesco Rubino; Anna Stears; David B Savage
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.